quinazolines has been researched along with Hypotension in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (68.75) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dixon, S; Fraser, LA; Hayward, J; Hwang, YJ; McArthur, E; Ordon, M; Welk, B | 1 |
| KOZMA, JJ | 1 |
| Forrest, J; Gittelman, M; Jacobs, S; Kim, D; Marks, LS; Roehrborn, CG | 1 |
| Chen, QQ; Deng, HW; Hu, GY; Li, D; Li, YJ; Luo, D; Qin, XP; Zeng, SY; Zhang, Z | 1 |
| Jee, LD; Opie, LH | 1 |
| Brunton, J; Meredith, P; Rubin, PC | 1 |
| Gerber, JG; Nies, AS; Olson, RD | 1 |
| Ballou, R; Glass, AR | 1 |
| Bèïque, L; Evans, MF; Por, CP | 1 |
| Jauernig, RA; Moulds, RJ | 1 |
| Rees, J; Williams, H | 1 |
| Timmermans, PB; Van Zwieten, PA | 1 |
| Bendall, MJ | 1 |
| Baloch, KH; Bendall, MJ; Wilson, PR | 1 |
| Gabriel, R; Hamtora, H; Meek, D | 1 |
2 trial(s) available for quinazolines and Hypotension
| Article | Year |
|---|---|
First dose efficacy of alfuzosin once daily in men with symptomatic benign prostatic hyperplasia.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Cross-Over Studies; Drug Administration Schedule; Humans; Hypotension; Male; Middle Aged; Prostatic Hyperplasia; Quinazolines; Safety; Treatment Outcome; Urodynamics | 2003 |
Are the new selective alpha-blockers better than non-selective alpha-blockers for benign prostatic hyperplasia?
Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Double-Blind Method; Humans; Hypotension; Male; Middle Aged; Placebos; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin | 1998 |
14 other study(ies) available for quinazolines and Hypotension
| Article | Year |
|---|---|
The risk of fall and fracture with the initiation of a prostate-selective α antagonist: a population based cohort study.
Topics: Accidental Falls; Adrenergic alpha-1 Receptor Antagonists; Aged; Canada; Craniocerebral Trauma; Fractures, Bone; Humans; Hypotension; Indoles; Male; Outcome Assessment, Health Care; Prostate; Prostatic Hyperplasia; Quinazolines; Retrospective Studies; Risk Factors; Sulfonamides; Tamsulosin | 2015 |
CLINICAL EVALUATION OF QUINETHAZONE-RESERPINE COMBINATION IN HYPERTENSION.
Topics: Antihypertensive Agents; Biomedical Research; Candidiasis, Oral; Diabetes Mellitus; Diuretics; Drug Therapy; Gout; Headache; Hypertension; Hypotension; Hypotension, Orthostatic; Polyuria; Quinazolines; Reserpine; Sulfonamides; Toxicology; Xerostomia | 1964 |
Calcitonin gene-related Peptide-mediated depressor effect and inhibiting vascular hypertrophy of rutaecarpine in renovascular hypertensive rats.
Topics: Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Vessels; Calcitonin Gene-Related Peptide; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension, Renovascular; Hypertrophy; Hypotension; Indole Alkaloids; Losartan; Male; Mesenteric Artery, Superior; Muscle, Smooth, Vascular; Quinazolines; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Vasodilator Agents | 2007 |
Acute hypotensive response to nifedipine added to prazosin in treatment of hypertension.
Topics: Adult; Drug Therapy, Combination; Humans; Hypertension; Hypotension; Male; Nifedipine; Prazosin; Quinazolines | 1983 |
Determination of the vasodilator UK33274 by high-performance liquid chromatography using fluorescence detection.
Topics: Chromatography, High Pressure Liquid; Doxazosin; Humans; Hypotension; Prazosin; Quinazolines; Vasodilator Agents | 1980 |
Prazosin does not alter canine renin release in response to systemic hypotension or intrarenal isoprenaline and prostaglandin I2 infusion.
Topics: Animals; Dogs; Epoprostenol; Hemodynamics; Hypotension; Infusions, Parenteral; Isoproterenol; Kidney; Natriuresis; Prazosin; Prostaglandins; Quinazolines; Renin | 1980 |
Pheochromocytoma, prazosin, and hypotension.
Topics: Adrenal Gland Neoplasms; Female; Humans; Hypotension; Middle Aged; Pheochromocytoma; Prazosin; Quinazolines | 1982 |
Anagrelide for essential thrombocythemia.
Topics: Adult; Child; Child, Preschool; Dose-Response Relationship, Drug; Edema; Fees, Pharmaceutical; Humans; Hypotension; Platelet Aggregation Inhibitors; Quinazolines; Tachycardia; Thrombocytosis | 1997 |
Mechanism of prazosin collapse.
Topics: Adrenergic alpha-Antagonists; Arteries; Dose-Response Relationship, Drug; Humans; Hypotension; In Vitro Techniques; Muscle, Smooth; Norepinephrine; Prazosin; Quinazolines | 1977 |
Letter: Adverse reactions to prazosin.
Topics: Antihypertensive Agents; Humans; Hypotension; Phosphodiesterase Inhibitors; Piperazines; Quinazolines; Time Factors; Vasodilator Agents | 1975 |
Influence of structural changes in the imidazolidine ring of clonidine on hypotensive activity.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Clonidine; Drug Evaluation, Preclinical; Heart Rate; Hypotension; Imidazoles; Male; Quinazolines; Rats; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Structure-Activity Relationship; Thiazoles | 1978 |
Side effects of prazocin.
Topics: Blood Pressure; Humans; Hypotension; Prazosin; Quinazolines; Research Design | 1976 |
Side effects due to treatment of hypertension with prazosin.
Topics: Adult; Aged; Antihypertensive Agents; Female; Humans; Hypertension; Hypotension; Male; Middle Aged; Piperazines; Quinazolines; Tachycardia | 1975 |
Letter: Adverse reactions to prazosin.
Topics: Humans; Hypotension; Piperazines; Quinazolines | 1975 |